CIK: 0001608126 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 14, 2024
Total Value ($000): $389,942 (96.6% shares, 3.4% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LBRDK | LIBERTY BROADBAND CORP | 1,886,260 | $107,951 | 27.7% | $63.56 | -2.6% | COM SER C | 530307305 |
| — | SPRINGWORKS THERAPEUTICS INC | 592,528 | $29,164 | 7.5% | $15.82 | — | COM | 85205L107 |
| ASND | ASCENDIS PHARMA A/S | 175,672 | $26,556 | 6.8% | $93.56 | — | SPONSORED ADR | 04351P101 |
| ARVN | ARVINAS INC | 539,100 | $22,254 | 5.7% | $42.13 | +3.7% | COM | 04335A105 |
| RVMD | REVOLUTION MEDICINES INC | 677,100 | $21,823 | 5.6% | $28.08 | +5.6% | COM | 76155X100 |
| SRPT | SAREPTA THERAPEUTICS INC | 158,457 | $20,514 | 5.3% | $116.29 | +5.3% | COM | 803607100 |
| ARGX | ARGENX SE | 50,000 | $19,686 | 5.0% | $393.72 | — | SPONSORED ADR | 04016X101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 360,916 | $18,129 | 4.6% | $43.35 | +25.1% | CLASS A ORD | 61559X104 |
| CYTK | CYTOKINETICS INC | 238,046 | $16,689 | 4.3% | $39.39 | +96.4% | COM NEW | 23282W605 |
| GLPG | GALAPAGOS NV | 503,759 | $16,221 | 4.2% | $45.86 | — | SPON ADR | 36315X101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 840,453 | $15,540 | 4.0% | $19.83 | +24.9% | COM | 004225108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 656,600 | $13,572 | 3.5% | $24.76 | 0.0% | COM NEW | 30233G209 |
| — | DISH NETWORK CORPORATION | 18,300,000 | $13,451 | 3.4% | $0.73 | — | NOTE 12/1 | 25470MAF6 |
| SLDB | SOLID BIOSCIENCES INC | 961,251 | $12,804 | 3.3% | $5.95 | +57.4% | COM NEW | 83422E204 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,649,221 | $12,715 | 3.3% | $16.38 | -48.5% | COM | 89422G107 |
| RLAY | RELAY THERAPEUTICS INC | 1,490,170 | $12,368 | 3.2% | $13.80 | -29.3% | COM | 75943R102 |
| PRTA | PROTHENA CORP PLC | 402,400 | $9,967 | 2.6% | $33.43 | -11.0% | SHS | G72800108 |
| — | CHURCHILL CAPITAL CORP VII | 548,000 | $175 | 0.0% | $0.92 | — | *W EXP 02/29/202 | 17144M110 |
| MNYWW | MONEYHERO LIMITED | 895,000 | $108 | 0.0% | $0.12 | — | *W EXP 09/13/202 | G6202B119 |
| — | CALIDI BIOTHERAPEUTICS INC | 125,000 | $71 | 0.0% | $3.33 | — | COM NEW | 320703101 |
| CNDAW | CONCORD ACQUISITION CORP II | 408,333 | $45 | 0.0% | $0.95 | — | *W EXP 99/99/999 | 20607U116 |
| CDAWF | COMPASS DIGITAL ACQUISITION CORP | 459,906 | $42 | 0.0% | $0.76 | — | *W EXP 09/29/202 | G2476C123 |
| CLDWW | CALIDI BIOTHERAPEUTICS INC | 655,200 | $34 | 0.0% | $0.50 | — | *W EXP 03/14/202 | 320703119 |
| IVCPW | SWIFTMERGE ACQUISITION CORP | 490,000 | $27 | 0.0% | $0.21 | — | *W EXP 12/13/202 | G63836111 |
| LSBWF | YS BIOPHARMA CO LTD | 489,999 | $25 | 0.0% | $0.16 | — | *W EXP 03/15/202 | G9845F117 |
| — | MARBLEGATE ACQUISITION CORP | 735,000 | $8 | 0.0% | $0.50 | — | *W EXP 08/31/202 | 56608A113 |